# Pharmacokinetic of Levodopa Study in Healthy Males

> **NCT03140956** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 20 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Levodopa, carbidopa, ODM-104

## Key facts

- **NCT ID:** NCT03140956
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-19
- **Primary completion:** 2017-07-03
- **Final completion:** 2017-08-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03140956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03140956, "Pharmacokinetic of Levodopa Study in Healthy Males". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03140956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*